Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
June 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Diagnostic scanning has become a critical first—and last—step in the repair process.
As 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US.
As employers are looking for efficient ways to keep work environments safe from COVID-19, Optis has developed Safe2Work, an app-enabled, web-based
Image
This week in our in-dept